Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $1.10 billion. The enterprise value is $748.43 million.
Important Dates
The next estimated earnings date is Monday, March 10, 2025, after market close.
| Earnings Date | Mar 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 157.22 million shares outstanding. The number of shares has increased by 76.20% in one year.
| Current Share Class | 157.22M |
| Shares Outstanding | 157.22M |
| Shares Change (YoY) | +76.20% |
| Shares Change (QoQ) | +0.70% |
| Owned by Insiders (%) | 0.75% |
| Owned by Institutions (%) | 63.78% |
| Float | 122.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 15.65 |
| Forward PS | 15.70 |
| PB Ratio | 3.12 |
| P/TBV Ratio | 3.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.01, with a Debt / Equity ratio of 0.21.
| Current Ratio | 13.01 |
| Quick Ratio | 12.59 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.77 |
Financial Efficiency
Return on equity (ROE) is -96.89% and return on invested capital (ROIC) is -34.47%.
| Return on Equity (ROE) | -96.89% |
| Return on Assets (ROA) | -27.36% |
| Return on Invested Capital (ROIC) | -34.47% |
| Return on Capital Employed (ROCE) | -31.47% |
| Revenue Per Employee | $230,120 |
| Profits Per Employee | -$652,951 |
| Employee Count | 267 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 46.60 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.91% in the last 52 weeks. The beta is 1.22, so OCUL's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -6.91% |
| 50-Day Moving Average | 8.17 |
| 200-Day Moving Average | 8.21 |
| Relative Strength Index (RSI) | 31.93 |
| Average Volume (20 Days) | 940,900 |
Short Selling Information
The latest short interest is 10.87 million, so 6.92% of the outstanding shares have been sold short.
| Short Interest | 10.87M |
| Short Previous Month | 11.16M |
| Short % of Shares Out | 6.92% |
| Short % of Float | 8.88% |
| Short Ratio (days to cover) | 11.85 |
Income Statement
In the last 12 months, OCUL had revenue of $61.44 million and -$174.34 million in losses. Loss per share was -$1.27.
| Revenue | 61.44M |
| Gross Profit | -47.18M |
| Operating Income | -142.86M |
| Pretax Income | -138.36M |
| Net Income | -174.34M |
| EBITDA | -139.06M |
| EBIT | -142.86M |
| Loss Per Share | -$1.27 |
Full Income StatementBalance Sheet
The company has $427.22 million in cash and $75.12 million in debt, giving a net cash position of $352.10 million or $2.24 per share.
| Cash & Cash Equivalents | 427.22M |
| Total Debt | 75.12M |
| Net Cash | 352.10M |
| Net Cash Per Share | $2.24 |
| Equity (Book Value) | 352.02M |
| Book Value Per Share | 2.25 |
| Working Capital | 436.65M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$117.70 million and capital expenditures -$1.55 million, giving a free cash flow of -$119.25 million.
| Operating Cash Flow | -117.70M |
| Capital Expenditures | -1.55M |
| Free Cash Flow | -119.25M |
| FCF Per Share | -$0.76 |
Full Cash Flow StatementMargins
Gross margin is -76.79%, with operating and profit margins of -232.51% and -283.74%.
| Gross Margin | -76.79% |
| Operating Margin | -232.51% |
| Pretax Margin | -283.74% |
| Profit Margin | -283.74% |
| EBITDA Margin | -226.33% |
| EBIT Margin | -232.51% |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -76.20% |
| Shareholder Yield | -76.20% |
| Earnings Yield | -15.84% |
| FCF Yield | -10.84% |
Analyst Forecast
The average price target for OCUL is $16.71, which is 138.71% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.71 |
| Price Target Difference | 138.71% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 56.91% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 1.47 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.47 |
| Piotroski F-Score | 3 |